We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

251270:KRXNetmarble Corp. Analysis

Data as of 2026-03-16 - not real-time

₩53,200.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Netmarble is trading at KRW 53,200, which sits below its 20‑day SMA (KRW 54,438) and 200‑day SMA (KRW 56,007) but remains just above the 50‑day SMA, indicating a mixed short‑term technical picture. The RSI of 49.5 and a bearish MACD histogram reinforce a neutral‑to‑slightly‑downward momentum, while volume is increasing, suggesting active participation. On the valuation side, the DCF‑derived fair value of roughly KRW 85,080 implies an upside of about 35%, and the forward P/E of 12.5 is well under the industry average of 17.9, pointing to an undervalued stock. Dividend yield stands at 1.65% with a payout ratio of 31.8%, supporting the case for income‑oriented investors.
Fundamentally, Netmarble posted 7.5% revenue growth, healthy operating margins (~12.8%) and a solid free cash flow generation of KRW 408 bn, offset by a high debt‑to‑equity of 26, though cash balances of KRW 762 bn provide a comfortable net‑debt cushion. The 30‑day volatility of 65% and a beta of 0.29 signal heightened price swings but limited market‑wide systematic risk. With a maximum drawdown of -32.7% and an “Extreme Greed” sentiment index, the stock offers attractive risk‑adjusted upside for patient investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and price below short‑term SMA
  • High short‑term volatility
  • Increasing volume indicating potential swing

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~35% and forward P/E below industry
  • Strong free cash flow and manageable payout ratio
  • Improving revenue growth and operating margins

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustained cash‑rich balance sheet despite debt levels
  • Undervalued relative to peers with growth potential
  • Stable dividend yield and low systematic (beta) risk

Key Metrics & Analysis

Financial Health

Revenue Growth7.50%
Profit Margin4.00%
P/E Ratio12.5
ROE2.07%
ROA2.12%
Debt/Equity25.95
Op. Cash Flow₩349.8B
Free Cash Flow₩408.1B
Industry P/E17.9

Technical Analysis

TrendNeutral
RSI49.5
Support₩0.00
Resistance₩58,900.00
MA 20₩54,437.50
MA 50₩52,374.00
MA 200₩56,007.00
MACDBearish
VolumeIncreasing
Fear & Greed Index79.45

Valuation

Fair Value₩85,079.80
Target Price₩71,863.63
Upside/Downside35.08%
GradeUndervalued
TypeBlend
Dividend Yield1.65%

Risk Assessment

Beta0.29
Volatility65.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.